On the adhesion arm, CDH2 expression consistently associates with aggressive behavior and reduced survival across tumor types; moreover, genetic reduction in CDH2 prolongs survival in a KPC pancreatic cancer model, underscoring its prognostic and therapeutic relevance [251,252]. This evidence concerns the gene CDH2 and pancreatic neoplasm.